The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial.

Nutrients · 2019 · PMC6836315 · PMID 31652512

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

only marginally significantno p-value reported

Regarding dietary factors, the increase in the adherence to MedDiet seemed to play a role in the decrease of liver fat percentage, while its association with lower values of ALT and liver stiffness was only marginally significant.

also in 5,076 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.